Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2026)

Fulgent Genetics has disclosed Other Non Operating Income across 4 years of filings, most recently posting $10000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $10000.0, down 85.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $95000.0 (down 84.92% YoY), and the FY2025 annual result was $153000.0, down 72.73% from the prior year.
• Other Non Operating Income came in at $10000.0 for Q1 2026 at Fulgent Genetics, down from $44000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $544000.0 in Q3 2024 to a low of -$22000.0 in Q4 2023.
• The 4-year median for Other Non Operating Income is $11000.0 (2024), against an average of $85272.7.
• Peak annual rise in Other Non Operating Income reached 855.56% in 2025, while the deepest fall reached 100.92% in 2025.
• Fulgent Genetics' Other Non Operating Income stood at -$22000.0 in 2023, then soared by 131.82% to $7000.0 in 2024, then soared by 528.57% to $44000.0 in 2025, then plunged by 77.27% to $10000.0 in 2026.
• The last three Other Non Operating Income figures came in at $10000.0 (Q1 2026), $44000.0 (Q4 2025), and -$5000.0 (Q3 2025), per Business Quant data.